Evaluation of the protective effect of a novel prostacyclin analog on mesenteric circulation following warm ischemia

European Surgical Research

Volumn 28, Issue 1, 1996, Pages 14-25

  Mashima, S ^a   Shirakami, G ^a   Mitsuyoshi, A ^a   Nakagami, M ^a   Morimoto, T ^a   Terasaki, M ^a   Nakao, K ^a   Yamabe, H ^b   Yamaoka, Y ^a   Ozawa, K ^c  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Endothelin; Intestinal ischemia; Mesenteric circulation; Prostacyclin analog

Indexed keywords

9 DEOXY 9ALPHA,6 NITRILO 15 (4 PROPYLCYCLOHEXYL) 16,17,18,19,20 PENTANORPROSTAGLANDIN F1 ALPHA METHYL ESTER; PROSTACYCLIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFICACY; FEMALE; INTESTINE ISCHEMIA; ISCHEMIA; LAPAROTOMY; MALE; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; SUPERIOR MESENTERIC ARTERY; SUPERIOR MESENTERIC VEIN;

ANIMAL; BLOOD PRESSURE; DOGS; ENDOTHELINS; EPOPROSTENOL; FEMALE; INTESTINES; ISCHEMIA; MALE; SPLANCHNIC CIRCULATION; SUPPORT, NON-U.S. GOV'T;

EID: 0029655447     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000129435     Document Type: Article

References (27)

1. Moncada S, Gryglewski RJ, Bunting S, Vane JR: An enzyme isolated from arteries transforms prostaglandin cndoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976;263:663.
2. Moncada S, Higgs EA, Vane JR: Human arterial and venous tissue generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1977;i: 18.
3. Ogletree ML, Lefer AM, Smith JB, Nicolaou KC: Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol 1979;56:95.
4. Araki H, Lefer AM: Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart. Circ Res 1980:47: 757.
5. Simpson PJ, Mitsos SE, Ventura A, Gallagher KP. Fantone JC, Abrams GD, Schork MA. Lucchesi BR: Prostacyclin protects ischemic re-perfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J 1987;113:129-137.
6. Feng LJ, Berger BE, Lysz TW, Shaw WW: Vasoactive prostaglandins in the impending no-reflow state: Evidence for a primary disturbance in nticrovascular tone. Plast Reconstr Surg 1988;81:755-764.
7. Hallenbeck JM, Furlow TW: Prostaglandin L and indomethacin prevent impairment of post-ischemic brain repcrfusion in the dog. Stroke 1979;10:629-637.
8. Monden M, Fortner JG: Twenty-four- and 48-hour canine liver preservation by simple hypothermia with prostacyclin. Ann Surg 1982; 196:38-42.
9. Sikujara O, Monden M, Toyoshima K. Okamura J, Kosaki G: Cytopro-tective effects of prostaglandin 12 on ischemia-induced hepatic cell injury. Transplantation 1983;36:238-243.
10. Tcrawaki T, Takakuwa T, Iguchi S, Wakitani K, Kira H, Okegawa T, Kawasaki A, Masuda Y: Effect of a prostacyclin analog OP-2507 on acute ischemic cerebral edema in cats. Eur J Pharmacol 1988; 152:63-70.
11. Masuda Y, Yasuba M, Zushi K, Ochi Y, Kadokawa T, Okegawa T: Effect of OP-2507, a stable prostacyclin analog on cerebral ischemia induced by unilateral ligation of common carotid artery in gerbils. Arch Int Pharmacodyn Ther 1988;294: 125-136.
12. Yanagisawa M, Kurihara S, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
13. Kurose I, Miura S, Fukuinura D, Suematsu M, Sekizuka E, Tashiro H, Serizawa H, Tsuchiya M: Intravital observation on the endothelin-induced hemodynamic changes in rat intestinal microvascular beds. J Vase Med Biol 1991;3:55-60.
14. Lerman A, Hildebrand FL Jr., Aarhus LL, Burnett JC Jr: Endothelin has biological actions at pathophysiological concentrations. Circulation 1991;83:1808-1814.
15. Bloom ITM, Bentley FR, Wilson MA, Garrison RN: In vivo effects of endothelin on the renal microcirculation. J Surg Res 1993:54:274-280.
16. Rakugi H, Tabuchi Y, Nakamaru M, Nagano M, Higashimori K, Mi-kami H, Ogihara T, Suzuki N: Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem Biophys Res Commun 1990;169:973-977.
17. Saito Y, Nakao K, Itoh H, Yamada T, Mukovama M, Arai H: Endothelin in human plasma and culture medium of aortic endothelial cells: Detection and characterization with radioimmunoassay using monoclonal antibody. Biochem Biophys Res Commun 1989;161:320-326.
18. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN: Intestinal mucosal lesion in low-flow states. Arch Surg 1970;101:478-483.
19. Palmer RMJ: Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 1987;327:524-526.
20. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H: Endothelial production of C-typc natriuretic peptide and its marked augmentation by transforming growth factor-P: Possible existence of 'vascular natriuretic peptide system. J Clin Invest 1992;90:1145-1149.
21. Fantone JC, Kinnes DA: Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils. Biochem Biophys Res Commun 1983; 113:506-512.
22. Fantone JC, Marasco WA, Elgas U, Ward PA: Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leucocyte lysosomal enzyme release and superoxide anion production. Am J Pathol 1984;115:9-16.
23. Beckman JS, Beckman TW, Chen J, Marshall PA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc natl Acad Sei USA 1990:87: 1620-1624.
24. Grisham MB, Hemandcz LA, Granger DN: Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986:251: G567-574.
25. De Nucei G, Thomas R, D’Orleans-Juste P, Antunes E, Wälder C, Warner TD, Vane JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sei USA 1988;85:9797-9800.
26. 25I-endothelin in the rat: Importance of pulmonary clearance. Biochem Biophys Res Commun 1990;167:1191-1195.
27. Parks DA, Granger DN: Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol 1986;250:G749-753.